Updated USPHS guidelines for managing occupational exposures to HBV, HCV, and HIV and considerations for dentistry

Journal of the American Dental Association

Volumn 133, Issue 12, 2002, Pages 1627-1629

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ARTICLE; BLOODBORNE BACTERIUM; CLASSIFICATION; DENTAL ASSISTANT; DENTIST; DISEASE TRANSMISSION; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN SERVICE TRAINING; MANDATORY REPORTING; OCCUPATIONAL EXPOSURE; PRACTICE GUIDELINE; RISK FACTOR; UNITED STATES;

ANTI-HIV AGENTS; BLOOD-BORNE PATHOGENS; DENTAL AUXILIARIES; DENTISTS; DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; INSERVICE TRAINING; MANDATORY REPORTING; OCCUPATIONAL EXPOSURE; RISK FACTORS; UNITED STATES;

EID: 0037704345     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.2002.0110     Document Type: Article

References (14)

1. U.S. Public Health Service, Centers for Disease Control and Prevention. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. MMWR Recomm Rep 2001;50(RR-11):1-52.
2. Bell DM. Occupational risk of human immunodeficiency virus infection in health care workers: an overview. Am J Med 1997;102(5B):9-15.
3. Ippolito G, Puro V, De Carli G. The risk of occupational human immunodeficiency virus infection in health care workers: Italian multicenter study - the Italian Study Group on Occupational Risk of HIV Infection. Arch Intern Med 1993;153:1451-8.
4. Mast ST, Woolwine JD, Gerberding JL. Efficacy of gloves in reducing blood volumes transferred during simulated needlestick injury. J Infect Dis 1993;168:1589-92.
5. Cardo DM, Culver DH, Ciesielski CA, et al. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group. N Engl J Med 1997;337:1485-90.
6. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternalinfant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994;331:1173-80.
7. Saba J, PETRA Trial Study Team. Interim analysis of early efficacy of three short ZDV/3TC combination regimens to prevent mother-to-child transmission of HIV-1: the PETRA trial (abstract S-7). Paper presented at: Sixth Conference on Retroviruses and Opportunistic Infections, Foundation for Retrovtrology and Human Health in scientific collaboration with the National Institute of Allergy and Infectious Diseases and the Centers for Disease Control and Prevention; Jan. 31-Feb. 4, 1999; Chicago.
8. Musoke P, Guay LA, Bagenda D, et al. A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006). AIDS 1999;13:479-86.
9. Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999;354:795-802.
10. Wade NA, Birkhead GS, Warren BL, et al. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus. N Engl J Med 1998;339:1409-14.
11. Jochimsen EM. Failures of zidovudine postexposure prophylaxis. Am J Med 1997;102(5B):52-5.
12. U.S. Public Health Service, Centers for Disease Control and Prevention. Update: universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings. MMWR Morb Mortal Wkly Rep 1988;37:377-82, 387-8.
13. U.S. Public Health Service, Centers for Disease Control and Prevention. Guidelines for prevention of transmission of human immunodeficiency virus and hepatitis B virus to health-care and public-safety workers. MMWR Morb Mortal Wkly Rep 1989;38(supplement 6):1-37.
14. U.S. Department of Labor, Occupational Health and Safety Administration. Occupational exposure to bloodborne pathogens: final rule. CFR Part 1910.1030. Fed Reg 1991;56:64004-182.